Results 181 to 190 of about 1,027,416 (202)
Some of the next articles are maybe not open access.
Reviewing novel treatment options for carbapenem-resistant Enterobacterales
Expert Review of Anti-infective TherapyCarbapenem resistant Enterobacterales (CRE) are a major threat to global health and hospital-onset CRE infections have risen during the COVID-19 pandemic. Novel antimicrobials are now available for the treatment of CRE infections. There remains an urgent need for new antimicrobials for CRE, especially for those producing metallo-β-lactamases.This ...
Natalie A, Mackow, David, van Duin
openaire +2 more sources
Prevalence of Carbapenem-Resistant Enterobacterales in a Tertiary Care Hospital
International Journal of Pharmaceutical Quality AssuranceBackground: Carbapenem-resistant Enterobacterales (CRE) pose a serious threat to patient safety in tertiary care hospitals, limiting treatment options and increasing morbidity and mortality. Aim: To evaluate the prevalence, species distribution, and carbapenem resistance patterns among Enterobacterales isolated from clinical specimens in a tertiary ...
Kumari Ritu +3 more
openaire +1 more source
Carbapenem resistance in Enterobacterales: Predicting clinical outcomes in bloodstream infections
Indian Journal of Medical MicrobiologyCarbapenem-resistant Enterobacterales (CRE) are a global concern due to their high mortality rates and limited therapeutics. CRE-caused bloodstream infections (BSIs) are challenging to manage, especially in healthcare settings. This study aimed to investigate the predictors of mortality in BSI patients caused by CRE.A single center prospective study to
openaire +2 more sources

